PROTAC 75 and PROTAC 76 were capable of inducing the tropomyosin 3 (TPM3)-TRKA fusion protein degradation in KM12 colorectal carcinoma cells and inhibiting downstream PLCγ1 signalling at sub-nanomolar concentrations. This evidence concerns the gene TPM3 and colorectal carcinoma.